Triple W
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Seed | ||
$1.1m | Early VC | ||
$4.2m | Series A | ||
$620k | Grant | ||
JPY500m | Series A | ||
JPY500m | Series A | ||
$9.1m | Series C | ||
* | JPY1.0b | Series D | |
Total Funding | $30.3m |
Recent News about Triple W
EditTriple W, the company behind DFree, is a pioneer in connected health devices, specifically targeting urinary incontinence. DFree is the first non-invasive, wearable device designed to give users advance notice of when they need to go to the bathroom, allowing them to manage their bladder health proactively. The device serves a wide range of clients, including individuals, family care providers, physicians, nurses, and professional care providers. Operating in the healthcare and medical device market, Triple W's business model revolves around the sale of the DFree device and its associated accessories, as well as potential subscription services for cloud-based monitoring. Revenue is generated through direct sales to consumers, partnerships with healthcare providers, and coverage under veteran benefits. The company's mission is to empower individuals to live independently without the constant worry of bladder issues.
Keywords: urinary incontinence, wearable device, non-invasive, bladder health, healthcare, medical device, remote monitoring, veterans benefits, connected health, proactive management.